Stock Research: Fulgent Genetics

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

Fulgent Genetics

NasdaqGM:FLGT US3596641098
28
  • Value
    88
  • Growth
    57
  • Safety
    Safety
    37
  • Combined
    51
  • Sentiment
    47
  • 360° View
    360° View
    28
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

Fulgent Genetics, Inc. is a technology-based company providing laboratory and therapeutic development services. Its main businesses include technical laboratory and testing services, professional interpretation of laboratory results, and developing drug candidates for treating cancers using a novel nanoencapsulation and targeted therapy platform. In the last fiscal year, the company had a market cap of $551 million, profits of $107 million, revenue of $283 million, and 1313 employees.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 28 (better than 28% compared with alternatives), overall professional sentiment and financial characteristics for the stock Fulgent Genetics are below the industry average. The 360° View is based on consolidating four consolidated indicators, with half of the metrics below and half above average for Fulgent Genetics. The consolidated Growth Rank has a good rank of 57, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. This means that growth is higher than for 57% of competitors in the same industry. In addition, the consolidated Safety Rank has a safer rank of 88 which means that the company has a financing structure that is safer than 88% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. But the consolidated Value Rank has a less desirable rank of 37 which means that the share price of Fulgent Genetics is on the higher side compared with typical size in indicators such as revenues, profits, and invested capital. This means that the stock price is higher than for 63% of alternative stocks in the same industry. The consolidated Sentiment Rank also has a low rank of 47, which means that professional investors are more pessimistic about the stock than for 53% of alternative investment opportunities. ...read more

more
Index
NASDAQ
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 21-Aug-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Growth
Shows a company's growth potential.
High Growth Tough Times
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
37 54 39 52
Growth
57 85 3 79
Safety
Safety
88 88 41 41
Sentiment
47 14 16 67
360° View
360° View
28 28 50 87
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
34 21 22 100
Opinions Change
90 50 50 50
Pro Holdings
n/a 8 1 1
Market Pulse
80 47 56 62
Sentiment
47 14 16 67
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
37 54 39 52
Growth
57 85 3 79
Safety Safety
88 88 41 41
Combined
51 51 6 6
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
84 84 84 83
Price vs. Earnings (P/E)
15 36 7 15
Price vs. Book (P/B)
74 84 84 56
Dividend Yield
1 1 1 1
Value
37 54 39 52
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
80 88 12 1
Profit Growth
10 94 10 86
Capital Growth
62 88 4 96
Stock Returns
45 21 37 69
Growth
57 85 3 79
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
83 85 86 82
Refinancing
94 96 94 78
Liquidity
15 15 100 100
Safety Safety
88 88 41 41

Similar Stocks

Discover high‑ranked alternatives to Fulgent Genetics and broaden your portfolio horizons.

Micron

NasdaqGS:MU
Country: USA
Industry: Semiconductors
Size: X-Large
Full Stock Analysis

Meta

NasdaqGS:FB
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

Alphabet

NasdaqGS:GOOG.L
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

Lithia Motors

NYSE:LAD
Country: USA
Industry: Automotive Retail
Size: X-Large
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.